阿摩線上測驗 登入

試題詳解

試卷:110年 - 110 國立臺灣大學_碩士班招生考試_臨床藥學研究所:臨床藥學及治療學#102126 | 科目:研究所、轉學考(插大)◆臨床藥學及治療學

試卷資訊

試卷名稱:110年 - 110 國立臺灣大學_碩士班招生考試_臨床藥學研究所:臨床藥學及治療學#102126

年份:110年

科目:研究所、轉學考(插大)◆臨床藥學及治療學

4. You are a member of the health care team for a 57-year-old womnan in whom hormone replacement therapy (HRT) is being considered for postmenopausal symptoms. Which one of the following statements is correct?
(A) Long-term systemic HRT use is linked to increased breast cancer risks. These risks could be eliminated completely afier HRT discontinuation.
(B) Risk varied among HRT types, with higher risks for combination estrogen-progestogen treatments and longer duration of usc.
(C) Adjustment for personal characteristics, smoking, alcohol intake, comorbidities, family history, and other prescribed drugs abolished the observed associations.
(D) Increased risk for combined progestogens was highest for dydrogesterone and lowest for norethisterone
正確答案:登入後查看

私人筆記 (共 1 筆)

私人筆記#5521165
未解鎖
正確答案是 (B):與HRT類型不同,使...
(共 458 字,隱藏中)
前往觀看
0
0